Search hospitals > Wisconsin > Johnson Creek
UW Cancer Center Johnson Creek
Claim this profileJohnson Creek, Wisconsin 53038
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Prostate Cancer
Conducts research for Skin Cancer
121 reported clinical trials
20 medical researchers
Summary
UW Cancer Center Johnson Creek is a medical facility located in Johnson Creek, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Skin Cancer and other specialties. UW Cancer Center Johnson Creek is involved with conducting 121 clinical trials across 180 conditions. There are 20 research doctors associated with this hospital, such as Kenneth B. De Santes, Nataliya V. Uboha, Kari B. Wisinski, and Ticiana A. Leal.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderER positive
HER2 positive
HER2 negative
Top PIs
Kenneth B. De SantesUniversity of Wisconsin Carbone Cancer Center6 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
57 reported clinical trials
104 drugs studied
Nataliya V. UbohaUniversity of Wisconsin Carbone Cancer Center5 years of reported clinical research
Studies Tumors
Studies Cancer
20 reported clinical trials
54 drugs studied
Kari B. WisinskiUniversity of Wisconsin Carbone Cancer Center6 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
17 reported clinical trials
49 drugs studied
Ticiana A. LealUniversity of Wisconsin Hospital and Clinics4 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
16 reported clinical trials
23 drugs studied
Clinical Trials running at UW Cancer Center Johnson Creek
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Squamous Cell Carcinoma
Ovarian Tumors
Esophageal Adenocarcinoma
Gastric Cancer
Pancreatic Carcinoma
Anal Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Omitting Radiation Therapy
for Breast Cancer
This study is evaluating whether a type of radiation therapy may help prevent breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at UW Cancer Center Johnson Creek?
UW Cancer Center Johnson Creek is a medical facility located in Johnson Creek, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Skin Cancer and other specialties. UW Cancer Center Johnson Creek is involved with conducting 121 clinical trials across 180 conditions. There are 20 research doctors associated with this hospital, such as Kenneth B. De Santes, Nataliya V. Uboha, Kari B. Wisinski, and Ticiana A. Leal.